Nonoperating Income (Expense) in USD of Lipocine Inc. from Q1 2017 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Lipocine Inc. quarterly and annual Nonoperating Income (Expense) history and change rate from Q1 2017 to Q3 2025.
- Lipocine Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $174,208, a 58% decline year-over-year.
- Lipocine Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $835,062, a 33% decline year-over-year.
- Lipocine Inc. annual Nonoperating Income (Expense) for 2024 was $1,164,068, a 26% decline from 2023.
- Lipocine Inc. annual Nonoperating Income (Expense) for 2023 was $1,579,630, a 16% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)